We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Labor... Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provide new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. Show more
NEW HAVEN, Conn., March 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its year end 2023 corporate update call on April 1st...
NEW HAVEN, Conn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that for the full year of 2023, its unaudited revenues have...
NEW HAVEN, Conn., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into a distribution agreement with Cardinal Health...
NEW HAVEN, Conn., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that continued revenue growth generated cash levels that bring...
NEW HAVEN, Conn., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into an agreement with a Japanese distributor for...
NEW HAVEN, Conn., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is pleased to welcome Christina Valauri to its board of directors effective...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.475 | -7.14285714286 | 6.65 | 6.705 | 5.71 | 2602 | 6.01498655 | CS |
4 | 0.035 | 0.57003257329 | 6.14 | 7 | 5.71 | 4750 | 6.4792772 | CS |
12 | -0.025 | -0.403225806452 | 6.2 | 7.25 | 5.71 | 5274 | 6.50754584 | CS |
26 | -1.395 | -18.428005284 | 7.57 | 8.99 | 5.0039 | 6168 | 6.8072953 | CS |
52 | -5.825 | -48.5416666667 | 12 | 14.8 | 4.7515 | 67705 | 7.67977697 | CS |
156 | -31.825 | -83.75 | 38 | 183.6 | 4.7515 | 1384488 | 88.74963079 | CS |
260 | -3.625 | -36.9897959184 | 9.8 | 216 | 4.7515 | 1276090 | 80.7096785 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions